ZMYM6NB Activators
The functional activity of the ZMYM6NB fusion protein can be influenced by a range of chemical compounds that target the distinct functionalities of the ZMYM6 and NB gene products. Retinoic acid, known for its role in neuronal differentiation, might enhance the NB component's involvement in neuroblastoma-related processes. Curcumin, with its wide-ranging effects on cell signaling, including pathways involved in proliferation and apoptosis, could impact both ZMYM6 and NB components, influencing cellular processes in neuroblastoma. Compounds like LY294002, a PI3K inhibitor, and Rapamycin, an mTOR inhibitor, could play a role in modulating cell survival and proliferation pathways, potentially affecting the functionality of both components of the fusion protein in the context of neuroblastoma. Trichostatin A, an HDAC inhibitor, may influence gene expression and protein acetylation, thus affecting both ZMYM6 and NB functions within the fusion protein, particularly in epigenetic regulation relevant to neuroblastoma.
Additionally, Spermidine and Resveratrol, known for promoting autophagy and influencing cellular aging and differentiation, might support the NB component's involvement in neuroblastoma-related processes within the fusion protein. Epigallocatechin gallate (EGCG), by modulating cell proliferation and apoptosis pathways, and 17-AAG (Tanespimycin), an HSP90 inhibitor affecting protein folding, could also influence the functional activity of both components of the fusion protein. Forskolin, through its effect on increasing cAMP levels, could potentially modulate the ZMYM6 component's function in cellular signaling processes. Bortezomib, a proteasome inhibitor, might additionally affect protein degradation pathways, influencing both ZMYM6 and NB components, particularly in pathways relevant to neuroblastoma cell survival and proliferation. Together, these compounds illustrate the complexity in modulating the activity of the ZMYM6NB fusion protein, reflecting the diverse functional aspects and regulatory mechanisms of its constituent parts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression and is involved in neuronal differentiation. It may enhance the NB component of the ZMYM6NB fusion protein, potentially affecting neuroblastoma-related processes where NB is implicated. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates various signaling pathways, including those involved in cell proliferation and apoptosis. This could affect both ZMYM6 and NB components of the fusion protein, influencing cellular processes in neuroblastoma. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can modulate cell signaling pathways. This might affect the ZMYM6 component of the ZMYM6NB fusion, particularly in pathways related to cell differentiation and development. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, could influence cellular signaling pathways related to cell survival and proliferation, potentially affecting both ZMYM6 and NB components of the fusion protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, involved in cell growth and proliferation. This inhibition could influence the functions of both ZMYM6 and NB components in the fusion protein, particularly in pathways related to neuroblastoma growth. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor, affecting gene expression and protein acetylation. This could influence the function of both ZMYM6 and NB in the fusion protein, particularly in epigenetic regulation relevant to neuroblastoma. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine promotes autophagy and may influence cellular aging and differentiation processes, potentially supporting the NB component's role in neuroblastoma-related processes within the fusion protein. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, influencing gene expression and cellular aging processes. This could support the NB component's role in neuroblastoma-related pathways in the ZMYM6NB fusion protein. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) modulates several signaling pathways, including those related to cell proliferation and apoptosis. EGCG could influence both components of the fusion protein in neuroblastoma signaling processes. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG is an HSP90 inhibitor that can affect protein folding and stability. It might indirectly influence the stability and function of the ZMYM6 component of the fusion protein. | ||||||